Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis

A Phase 1b/2a clinical trial of NDV-3A vaccine containing a recombinant Als3 protein formulated with alum protected women

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in immunology 2018-06, Vol.9, p.1349-1349
Hauptverfasser: Uppuluri, Priya, Singh, Shakti, Alqarihi, Abdullah, Schmidt, Clint S, Hennessey, Jr, John P, Yeaman, Michael R, Filler, Scott G, Edwards, John E, Ibrahim, Ashraf S
Format: Artikel
Sprache:eng
Schlagworte:
Als3p
Candida albicans, RVVC
Immunology
NDV-3
NDV-3A
vaccine
virulence
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A Phase 1b/2a clinical trial of NDV-3A vaccine containing a recombinant Als3 protein formulated with alum protected women
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.01349